ProC® Global: the first functional screening assay for the complete protein C pathway
Authors:
Open Access
- 1 September 1997
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 43 (9) , 1719-1723
Abstract
In clinical practice, venous thromboembolic complications are much more frequent than bleeding disorders. In fact, disturbances within the protein C pathway due to coagulation factor V (FV) Leiden mutation and deficiency of protein C or protein S are the most frequent abnormalities in hereditary thrombophilia. Furthermore, acquired dysfunctions of the protein C system may predispose the single individual to an increased thrombotic risk. A routine-suited screening assay that would allow the monitoring of the proper interplay of factors in the protein C pathway could add an important factor to the basic coagulation profile. This consists of the prothrombin time and of the activated partial thromboplastin time, which currently allow only a screening for increased risk for bleeding but not for venous thromboembolism. A new functional screening test for the protein C system such as the presented ProC® Global should therefore facilitate detection of FV Leiden as well as deficiency of protein C and protein S. The results of the present evaluation indicate that ProC Global is highly sensitive to activated protein C resistance/FV Leiden (100%) and protein C deficiency (90%) and sensitive to protein S deficiency (63%). Furthermore, the assay gives a quantitative measure of the net potential of the protein C pathway in relation to the intrinsic procoagulant system. The use of this assay for a prospective assessment of thromboembolic risk is the subject of current studies.Keywords
This publication has 9 references indexed in Scilit:
- Inherited Thrombophilia: Part 1Thrombosis and Haemostasis, 1996
- Guidelines for the management of thrombophilia. Department of Haematology, The Royal London Hospital, Whitechapel, London, UKPostgraduate Medical Journal, 1996
- The PACT—A simple screening assay for assessing the functionality of the protein C anticoagulant pathwayThrombosis Research, 1995
- Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study) [see comments]Blood, 1995
- Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosisThe Lancet, 1995
- Factor VII and Fibrinogen Levels as Risk Factors for Venous ThrombosisThrombosis and Haemostasis, 1994
- Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia StudyThe Lancet, 1993
- Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.Proceedings of the National Academy of Sciences, 1993
- Protein S and protein C: Biochemistry, physiology, and clinical manifestation of deficienciesTrends in Cardiovascular Medicine, 1992